Next Generation Sequencing Enables the Development of a Blood Test to Detect Cancer
A new study showed that a blood-based multi-cancer early detection test (MCED test) provided signals of potential cancer in 1.4% of otherwise healthy study subjects. Out of the 93 people whose tests showed the signals, 35 were then diagnosed with cancer using standard diagnostic tools. The specificity of the MCED was more than 99%, and …
Next Generation Sequencing Enables the Development of a Blood Test to Detect Cancer Read More »
